ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,880.00
0.44%
다우존스 지수
40,211.72
0.53%
Bitcoin
63,614.33
4.66%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. PROCEPT BioRobotics Corporation (PRCT)

  7. PROCEPT BioRobotics Corporation (PRCT) 뉴스

PRCT

PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PRCT
일자시간출처헤드라인심볼기업
2024/02/1007:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/02/0907:30GlobeNewswire Inc.CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of DirectorsNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/02/0809:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/02/0809:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/01/1207:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/01/1207:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2024/01/0907:00GlobeNewswire Inc.PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 millionNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/1608:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/1608:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/0910:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/0910:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/0907:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/0709:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/12/0709:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/1506:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/1408:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/1406:03GlobeNewswire Inc.PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York CityNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/0305:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/0205:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/11/0205:02GlobeNewswire Inc.PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue GuidanceNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/10/1905:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/10/1705:05GlobeNewswire Inc.PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023NASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/10/1221:00GlobeNewswire Inc.The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" RecommendationNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/09/2021:00GlobeNewswire Inc.PROCEPT BioRobotics Announces New Corporate Headquarters in San JoseNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/09/1305:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/09/1221:00GlobeNewswire Inc.PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate CancerNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/08/2221:00GlobeNewswire Inc.PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in JapanNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/08/1805:05GlobeNewswire Inc.PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in BostonNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/08/1621:00GlobeNewswire Inc.NorthShore University HealthSystem offers expanded access to treat most common prostate ailmentNASDAQ:PRCTPROCEPT BioRobotics Corporation
2023/08/0505:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
 검색 관련기사 보기:NASDAQ:PRCT

최근 히스토리

AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유